EP3820856
C-MANNÓSÍÐ EFNASAMBÖND GAGNLEG TIL AÐ MEÐHÖNDLA ÞVAGFÆRASÝKINGAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.7.2019EP published:
31.8.2022EP application number:
19769220.5
EP translation filed:
31.10.2022Grant published:
15.1.2023EPO information:
European Patent Register
Max expiry date:
7.7.2039Expiry date:
7.7.2026Next due date:
31.7.2026
Title in English:
C-MANNOSIDE COMPOPUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONSLanguage of the patent:
English
Timeline
Today
8.7.2019EP application
31.8.2022EP Publication
31.10.2022Translation submitted
15.1.2023Registration published
7.7.2026Expires
Owner
Name:
GlaxoSmithKline Intellectual Property Development LimitedAddress:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
Name:
Fimbrion Therapeutics, Inc.Address:
20 South Sarah Street, Saint Louis MO 63108, US
Inventor
Name:
BISHOP, Michael JosephAddress:
Research Triangle Park, NC 27709, US
Name:
COLANDREA, Vincent J.Address:
Collegeville, PA 19426, US
Name:
LI, YuehuAddress:
Collegeville, PA 19426, US
Name:
STEWART, Eugene L.Address:
Collegeville, PA 19426-0989, US
Name:
STRAMBEANU, IuliaAddress:
Collegeville, PA 19426, US
Name:
WIDDOWSON, Katherine LouisaAddress:
San Diego, CA 92106, US
Name:
JANETKA, James WalterAddress:
Saint Louis, MO 63108, US
Name:
MCGRANE, Laurel KathrynAddress:
Saint Louis, MO 63108, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862695993 PDate:
10.7.2018Country:
US
Number:
201862755588 PDate:
5.11.2018Country:
US
Classification
Categories:
C07D 309/10, A61P 31/04, A61K 31/7034
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 22.6.2023
Expires: 7.7.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 19.6.2024
Expires: 7.7.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.7.2025
Expires: 7.7.2026
Payer: Árnason Faktor ehf.